Search filters

List of works by Christelle de la Fouchardière

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.

scientific article

Activity and Safety of Sunitinib in Patients with Advanced Radioiodine Refractory Thyroid Carcinoma: A Retrospective Analysis of 57 Patients.

scientific article published in August 2016

BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases

scientific article published on 10 June 2019

Characteristics of BRAF V600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

scientific article published on 31 May 2019

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

scientific article published in September 2017

Comment on: "Regorafenib: Start Low and Go Slow"

scientific article published on 01 February 2016

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

scientific article published on 25 August 2017

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects

scientific article published on 26 April 2017

Effect of Buparlisib, a Pan-Class I PI3K Inhibitor, in Refractory Follicular and Poorly Differentiated Thyroid Cancer

scientific article published on 01 September 2018

Erratum to 'Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)' [Eur J Cancer 107 (January 2019) 46-52]

scientific article published on 19 July 2019

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

scientific article published on 25 July 2016

Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial

scientific article published on 21 November 2019

FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study

scientific article published on 01 August 2019

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial

scientific article published on 23 May 2019

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

scientific article published on 01 February 2019

Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance

scientific article published on 02 July 2019

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.

scientific article

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study

scientific article published on 08 June 2020

Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis

scientific article published on 04 June 2019

Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

scientific article published on April 2016

Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)

scientific article published on 07 December 2018

Predictive factors of outcome in poorly differentiated thyroid carcinomas

scientific article published on 2 February 2018

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

scientific article published on 01 June 2019

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

scientific article published on 07 October 2020

Regorafenib in the treatment of metastatic colorectal cancer.

scientific article

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

scientific article

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer

scientific article published on 10 November 2018

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBACCA) nested within a compassionate use program

scientific article

TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma

scientific article published on 12 January 2019

Targeted treatments of radio-iodine refractory differentiated thyroid cancer.

scientific article published on February 2015

The medical treatment of radioiodine-refractory differentiated thyroid cancers in 2019. A TUTHYREF® network review

scientific article published on 11 June 2019

Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

scientific article published on 25 October 2017

Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

scientific article published on 01 July 2019

Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma

scientific article

Paulina is supported by:

About Paulina

Help